Research ArticleFEATURED BASIC SCIENCE ARTICLE
Open Access
Cure of Disseminated Human Lymphoma with [177Lu]Lu-Ofatumumab in a Preclinical Model
Kyuhwan Shim, Mark S. Longtine, Diane S. Abou, Mark J. Hoegger, Richard S. Laforest, Daniel L.J. Thorek and Richard L. Wahl
Journal of Nuclear Medicine April 2023, 64 (4) 542-548; DOI: https://doi.org/10.2967/jnumed.122.264816
Kyuhwan Shim
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
Mark S. Longtine
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
Diane S. Abou
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
Mark J. Hoegger
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
Richard S. Laforest
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
Daniel L.J. Thorek
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
2Department of Biomedical Engineering, Washington University, St. Louis, Missouri; and
Richard L. Wahl
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri;
3Department of Radiation Oncology, Washington University, St. Louis, Missouri
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 64, Issue 4
April 1, 2023
Cure of Disseminated Human Lymphoma with [177Lu]Lu-Ofatumumab in a Preclinical Model
Kyuhwan Shim, Mark S. Longtine, Diane S. Abou, Mark J. Hoegger, Richard S. Laforest, Daniel L.J. Thorek, Richard L. Wahl
Journal of Nuclear Medicine Apr 2023, 64 (4) 542-548; DOI: 10.2967/jnumed.122.264816
Jump to section
Related Articles
Cited By...
- No citing articles found.